glp-1+nad+ Huff's Microdosing GLP-1 | AgelessRx

A green cast points to a changed ligand environment or partial dissociation

Ogawa K, Kuse Y, Tsuruma K, Kobayashi S, Shimazawa M, Hara H

They help the body metabolise carbohydrates, proteins, and fats properly, improving nutrient utilisation, which is essential for health maintenance

Its comparison table puts GLP-1 agonists at a 25 to 50 mg/dL fasting glucose reduction, which is the gap the post is drawing attention to

None is FDA-approved for any of the uses being marketed, and the evidence supporting the wellness claims being made for them ranges from limited to essentially nonexistent

Hernandez NS, Weir VR, Ragnini K, Merkel R, Zhang Y, Mace K, et al